Business Standard

Why race for coronavirus vaccine could leave developing countries behind

The UN, International Red Cross and Red Crescent, and others said it was a moral imperative that everyone have access to a "people's vaccine"

testing, private laboratories, labs, vaccines, doctors, nurses, health, coronavirus
Premium

Executives at Pfizer and some other major drug makers say they oppose suspending patent rights for potential Covid-19 vaccines.

AP London
As the race for a vaccine against the new coronavirus intensifies, rich countries are rushing to place advance orders for the inevitably limited supply to guarantee their citizens get immunised first - leaving significant questions about whether developing countries will get any vaccine before the pandemic ends.
Earlier this month, the UN, International Red Cross and Red Crescent, and others said it was a moral imperative that everyone have access to a "people's vaccine". But such grand declarations are unenforceable, and without a detailed strategy, the allocation of vaccines could be extremely messy.
"We have this beautiful picture of everyone getting the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in